Record ID | marc_loc_2016/BooksAll.2016.part36.utf8:119039428:2497 |
Source | Library of Congress |
Download Link | /show-records/marc_loc_2016/BooksAll.2016.part36.utf8:119039428:2497?format=raw |
LEADER: 02497cam a22004214a 4500
001 2009020581
003 DLC
005 20110913082854.0
008 090518s2010 fluaf b 001 0 eng
010 $a 2009020581
015 $aGBA979542$2bnb
016 7 $a101505204$2DNLM
016 7 $a015347326$2Uk
020 $a9781439804742 (hardcover : alk. paper)
020 $a1439804745 (hardcover : alk. paper)
035 $a(OCoLC)ocn338288680
040 $aDNLM/DLC$cDLC$dBTCTA$dNLM$dC#P$dUKM$dUBY$dDLC
042 $apcc
050 00 $aQH345$b.H43 2010
060 00 $a2009 M-261
060 10 $aQV 778$bH461b 2010
082 00 $a615/.3$222
100 1 $aHefferon, Kathleen L.
245 10 $aBiopharmaceuticals in plants :$btoward the next century of medicine /$cKathleen Laura Hefferon.
260 $aBoca Raton :$bCRC Press,$cc2010.
300 $axvii, 206 p., [4] p. of plates :$bill. (some col.) ;$c25 cm.
504 $aIncludes bibliographical references and index.
505 0 $aHistory of plants in production of biopharmaceuticals -- Transgenic plants expressing vaccine and therapeutic proteins -- Chloroplast engineering and production of biopharmaceuticals -- Plant viral expression vectors and production of biopharmaceuticals in plants -- Glycosylation of therapeutic proteins in plants -- Scale-up of plant-derived pharmaceuticals : prospects for commercial production and for global health -- The immune response to plant-derived biopharmaceuticals -- Risk analysis and safety of plant-made biopharmaceuticals -- Epilogue : the future.
520 $a"Transgenic plants present enormous potential to become one of the most cost-effective and safe systems for large-scale production of proteins for industrial, pharmaceutical, veterinary, and agricultural uses. Over the past decade, much progress has been made with respect to the development of vaccines, antibodies, and other therapeutic proteins. Biopharmaceuticals in Plants: Toward the Next Century of Medicine provides a comprehensive survey of all major aspects of the development and production of plant-made biopharmaceuticals."--Publisher's description.
650 0 $aBiological products.
650 0 $aTransgenic plants.
650 0 $aPlant genetic regulation.
650 0 $aPharmaceutical technology.
650 12 $aBiological Products.
650 12 $aPlants, Genetically Modified$xmetabolism.
650 22 $aGene Expression Regulation, Plant.
650 22 $aPlant Extracts.
650 22 $aTechnology, Pharmaceutical.